ArticleMaterials (Basel, Switzerland)2024
Experimental Study on the Effects of Tapioca Starch on Cement Mortar Quality Improvement.
Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In this study, the effect of tapioca starch (TP) on mortar was evaluated by incorporating TP into the mortar mixture. The evaluation involved analyzing the mortar's quality characteristics, performance, and fundamental quality improvements. The addition of TP resulted in a decrease in flow, which was attributed to increased viscosity. Specifically, a 10% reduction in flow was observed with a 0.025% increase in TP content. After 28 days, the impact of TP on the compressive strength of the mortar remained consistent, regardless of the TP amount. However, within the first 3 days, higher TP content accelerated strength development, with early compressive strength increasing by up to 20% at a 0.050% TP level. Additionally, bond strength improved by approximately 60% at a 0.050% TP concentration, and final shrinkage was reduced by 5%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.